MUKKA PROTEINS LIMITED (MUKKA)

NSE: ₹21.96
BSE: ₹21.96
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 516.99 256.70 172.50 149.19 303.15 381.57 170.77 244.58 653.50 380.60
YOY Revenue Growth % - - - - -41.36% 48.65% -1% 63.94% 115.57% -0.25%
Other Income 6.18 4.73 2.85 3.14 5.80 4.15 2.55 6.00 4.93 15.19
Total Income 523.17 261.43 175.35 152.33 308.95 385.72 173.33 250.58 658.43 395.80
Total Expenses + 507.44 234.47 169.63 152.11 276.50 365.53 170.52 240.86 626.65 367.04
Cost of Materials Consumed 548.85 289.20 190.42 129.23 341.86 254.60 192.85 280.45 581.97 375.46
Employee Benefit Expense 7.98 7.67 6.99 8.31 8.43 8.57 7.89 8.94 10.82 13.13
Other Expenses 37.12 24.94 21.11 19.07 32.48 31.91 19.01 26.24 46.29 33.23
Operating Profit 9.55 22.23 2.87 -2.91 26.65 16.04 0.25 3.73 26.85 13.57
OPM % 1.8% 8.7% 1.7% -2% 8.8% 4.2% 0.1% 1.5% 4.1% 3.6%
Profit Before Tax + 15.73 26.96 5.73 0.23 32.45 20.19 2.81 9.72 31.78 28.76
Tax Expense 3.66 -2.20 0.47 -1.25 5.65 6.19 1.22 2.84 4.53 7.40
Tax % 23.3% -8.1% 8.2% -553.7% 17.4% 30.7% 43.4% 29.2% 14.3% 25.7%
Profit After Tax 12.07 29.15 5.26 1.47 26.80 14.00 1.59 6.88 27.25 21.36
EPS (Basic) 0.48 1.20 0.14 0.07 0.88 0.45 0.05 0.20 0.79 0.69

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024
Revenue from Operations 1,449.45 1,006.42 1,379.83
YOY Revenue Growth % 44.02% -27.06% -
Other Income 28.68 15.12 19.42
Total Income 1,478.13 1,021.53 1,399.25
Total Expenses + 1,405.06 962.33 1,311.79
Cost of Materials Consumed 1,430.73 916.10 1,326.88
Employee Benefit Expense 40.78 32.30 29.33
Other Expenses 124.77 104.56 109.51
Operating Profit 44.39 44.08 68.04
OPM % 3.1% 4.4% 4.9%
Profit Before Exceptional 73.08 59.20 87.46
Exceptional Items 0.00 0.00 0.00
Profit Before Tax + 73.08 59.20 87.46
Tax Expense 15.99 11.10 13.15
Tax % 21.9% 18.8% 15%
Profit After Tax 57.09 48.10 74.31
EPS (Basic) 1.74 1.55 3.10

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024
ASSETS
Non-Current Assets + 332.30 150.60 124.27
Property, Plant & Equipment 163.92 85.86 83.50
Capital Work in Progress 30.47 8.56 0.00
Non-Current Investments 55.84 36.66 31.10
Goodwill 14.05 6.75 0.00
Other Intangible Assets 14.53 0.07 0.08
Current Assets + 1,288.83 925.73 816.52
Inventories 856.55 564.25 423.25
Trade Receivables 181.83 199.82 185.34
Cash and Cash Equivalents 12.88 3.08 94.44
Current Investments 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 528.78 456.50 408.31
Equity Share Capital 30.00 30.00 30.00
Other Equity 469.09 410.70 366.09
Non-Current Liabilities 43.42 8.80 11.56
Current Liabilities 1,048.93 611.02 520.93
Total Liabilities 1,092.35 619.82 532.49

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024
Cash from Operating Activities -111.27 -111.93 -150.41
Cash from Investing Activities -145.98 -34.99 -47.59
Cash from Financing Activities 267.05 55.55 265.89
Net Increase/Decrease in Cash 9.81 -91.36 67.89